Navigation Links
Bacterial discovery may help CF patients

Microbiologists from Australian and Danish have discovered a way to prevent or disturb the formation of bacterial colonies, which they believe may bring a string of benefits from preventing lung infections in cystic fibrosis sufferers to cleaner contact lenses.// The discovery, by scientists at the University of Queensland's Institute for Molecular Bioscience and the Technical University of Denmark, was released Friday and is published in the journal Science.

Researchers found a DNA-destroying enzyme, called DNaseI, may break up or disrupt the formation of stubborn biofilms of the bacteria Pseudomonas aeruginosa. Biofilms are communities of bacteria enmeshed in a matrix of long, chain-like molecules, which includes DNA. When biofilms form in the human body, as they frequently do in the lungs of people with cystic fibrosis, they are particularly resistant to antibiotics and the body's own immune response.

Cystic fibrosis is a genetic disease characterized by the build up of thick sticky mucus in the lungs and pancreas, leading to breathing difficulties and nutritional problems.Co-author of the paper, Professor John Mattick, said infection by this bacteria resulted in inflammation and tissue damage in the lungs of cystic fibrosis patients.

"During lung infection, Pseudomonas aeruginosa creates a biofilm, a soup rich in proteins, complex sugars and DNA. This biofilm plays a vital role in establishing bacterial colonies that are also resistant to antibiotics and the host's immune response," Mattick said.

Scientists have known for a while the biofilm of this pathogen has a high DNA content but they thought the DNA in the matrix was not an important part of the biofilm structure. The new research found the majority of the matrix material in the biofilm consists of DNA, and that it seems to be released by the living bacteria.

The researchers found treating the biofilm with the DNaseI enzyme, which breaks down DNA into its component molecules, destroys the biofilm and restricts the establishment of infectious colonies. It appears DNaseI treatment may also be beneficial as an early prophylactic measure to prevent the establishment of bacterial infection in the lungs of people with cystic fibrosis.

However, while DNaseI dissolved the biofilm during its early stages of growth, it became less effective over the next 84 hours. The authors propose the matrix in mature biofilms may be strengthened by other substances or that mature biofilms may produce sufficient counter-enzymes to locally inactivate the DNaseI.

Mattick's co-author, Dr. Cynthia Whitchurch, told United Press International her research began several years when she started wondering whether DNA might have a structural role. "It was a fortunate observation," she said. She said while more research is needed, she is hopeful the discovery will be useful in other settings where biofilm form, such as inside catheter tubes and on the surface of contact lenses.Professor Staffan Kjelleberg, a microbiologist who specializes in biofilms at the University of New South Wales, was surprised when he heard of the discovery.

"The discovery that DNA is the major component of the matrix, and the use of DNaseI to dissolve it is a breakthrough," he Kjelleberg told UPI. "My question is, is it also relevant to other biofilms or only those pertaining to Pseudomonas. You see, there are many types of biofilm, and they are formed everywhere there's an aqueous environment. So the possibilities here are endless."


'"/>




Related medicine news :

1. Cure for Bacterial Meningitis
2. Molecule That Aids Bacterial Infections Identified
3. Bacterial Photographs Created By Student Scientists!
4. Bacterial infestation in food very critical!
5. Whirlpool Bath Tubs Contain Potentially Lethal Bacterial Strains
6. Children Of Smoking Parents Face Increased Risk Of Bacterial Infection
7. Petting Zoos Can Lead To Bacterial Infection And Illness
8. Treatment of Bacterial Infection Paves the Way to Treat CF Infection
9. ‘Biofilms’-Clumped Bacterial Slime Cause Ear Infectin
10. PGLYRP Proteins Prevent Bacterial Infections
11. Solution to Bacterial Mystery Promises New Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... Guide ...      , No matter on which side of the Atlantic devicemakers do ... device regulations they have to follow. , In addition to the full text of ...
(Date:6/28/2017)... ... , ... Anyone with a remote control has seen the never-ending twists on the house flipping ... get rich in no time. But what about the buyers of the flipper's flip. ... of a flipped house. An email recently sent to Gary Case said, “Just closed ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... ... , ... American Farmer proudly announces the participation of Pure Line Seeds, Inc ... to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... seed. As demand grew, the small company located in Moscow, Idaho extended its sales ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: